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Introduction: Use of electrocautery in oesophagectomy is standard; however, the introduction of the
harmonic scalpel (HS) and its use has changed the methodology of oesophagectomy in recent years. We
have assessed the efﬁciency of HS in oesophageal cancer surgery. The parameters studied were blood
loss, transfusion rates, and postoperative complications.
Methods: Our cohort included 142 patients who underwent elective oesophagectomy from January 1999
to December 2004. The control group was the patients undergoing electrocautery oesophagectomy
(n ¼ 98) between 1999 and 2002. Furthermore, 44 patients who were operated with the HS were
included in the study group.
Results: The numbers of units transfused were signiﬁcantly less in HS group (median 0) in comparison
with controls (median 2), p ¼ 0.003. Median blood loss in HS and the controls was 500 and 700 ml
respectively (p ¼ 0.123). Mortality in HS group was 2.27%compared to 3.06% in controls (p ¼ 0.14). The
complication (principally respiratory) rate was only 13.6% of patients in HS group compared to 17.3% in
the controls.
Conclusion: Our study shows that HS reduces transfusion rates and postoperative complications, high-
lighting it as a safe and effective alternative to traditional electrocautery.
 2009 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
Oesophageal cancer is the ﬁfth most common cause of cancer
death in the world.1,2 The prognosis of oesophageal carcinoma both
squamous and adenocarcinoma, is dismal with frequent metastasis
and low survival rate despite surgical resection.3
Despite improvements in multimodality therapy, especially
chemotherapy survival has not improved signiﬁcantly, suggesting
the alternative strategies for treating the disease.4 Therefore the
mainstay of the treatment remains the surgical resection with
improvement in recent years.5
However surgery carries a major risk of insult to physiological
status of the patient as well as increased morbidity and mortality.
Grifﬁn et al. highlighted the importance of facilities and expertise
available for careful selection of a patient, in order to reduce the
morbidity and mortality.6
Until the introduction of harmonic scalpel (HS) in the 1990’s,
traditionally electrocautery was widely used in surgical practise. HSld Congress of the European
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Elsevier Ltd on behalf of Surgical A(transmits a high frequency ultrasonic energy), for tissue cutting
and coagulation at low temperature and in selective manner
causing less tissue injury and is an effective replacement to elec-
trocautery and laser.7
The principle behind its operation is transformation of the
electric power into longitudinal movement of the working part of
the instrument, by a piezoelectric transducer situated in the hand
piece.8 Its mechanism of action in varying degrees involves: cavi-
tations, heat generation and protein denaturation. The process of
cavitation arises from the creation, expansion and implosion of
cavities in liquids. Mechanical oscillation of the instrument causes
rapid rise and fall in temperature of the tissues. Once pressure falls
below the level of vapour pressure of cellular ﬂuid, vapour ﬁlled
cavities are formed within cells. It is the force generated by
expansion and contraction of these that results in tissue dissection.
Heat generated by HS is the result of internal tissue fraction caused
by high frequency vibrations. In addition coagulation is produced
by denaturing proteins through mechanical disruption of tertiary
hydrogen bonds.9 HS causes minimal tissue charring and dissection
and eliminates thermal injury in thoracic surgery.10
In addition HS has been designated as less hazardous because of
bloodless operative ﬁeld and not arrhythmogenic to the heart.11
Moreover one experimental study showed signiﬁcantly less
necrosis in nerves12 and therefore less postoperative neuralgia.ssociates Ltd.
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ment, less postoperative blood loss therefore subsequently less re-
exploration rate.13 Another experimental study describes further
advantages of HS including less muscle damage, easier operation
due to less muscle twitching, bloodless and smokeless operative
ﬁeld and good haemostasis.14
In patients with cancer, many factors in addition to allogenic
blood transfusion, such as time of surgery, amount of blood loss,
stage of disease and magnitude of the surgical procedure, relate to
outcomes.15 HS has widely been used in different procedures
including CABG, harvesting of internal mammary artery and radial
artery,16 gynaecological procedures,17 head and neck surgery and
lung surgery.18 However its use in surgery for malignant diseases of
oesophagus has not been assessed so far. HS is a costly piece of
machinery and the approximate prevailing price is £12,000.
However it is commonly used in all hospitals of the UK.
The aim of the study was to assess the efﬁciency of HS in
oesophageal cancer surgery. The parameters studied were blood
loss, transfusion rates, and postoperative complications.
2. Materials and methods
All patients were divided into two age-controlled groups.
Control group (Group 1) consists of patients who had oesopha-
gectomy by using conventional electrocautery. Study group (Group
2) patients were operated on with the HS.
2.1. Patients selection
All the patients who underwent curative oesophageal resection
for cancer of the oesophagus at Derby upper GI cancer services
(DUGICS) were included in the study. A dedicated team of surgeons,
anaesthetists and pathologists managed all the patients. All cases
were discussed preoperatively and postoperatively in a multidisci-
plinary team (MDT) meeting to decide the optimal treatment for
each individual patient. All patients had upper GI endoscopy,
staging computed tomography (CT) scan, preoperative assessment
and staging laparoscopy prior to surgical resection. Data was
collected for patients who underwent elective oesophagectomy
from 1999 to 2004. Harmonic scalpel (HS) was introduced at Der-
byshire Royal Inﬁrmary in January 2003.
All the patients were selected from single surgeons practice. He
was operating as consultant since 1995. In order to exclude expe-
rience gained or learning curve bias patients selected from 1999
onwards.
2.1.1. Inclusion criteria
Patients with operable cancer of the oesophagus.
Patients with gastro-oesophageal junction (GOJ) cancer.
Patients who underwent elective, potentially curative resection.Table 1
T-stage and N-stage of tumours.
Harmonic scalpel Electrocautery
T1 n ¼ 05 n ¼ 03
T2 n ¼ 14 n ¼ 13
T3 n ¼ 25 n ¼ 80
N0 n ¼ 14 n ¼ 45
N1 n ¼ 30 n ¼ 532.1.2. Exclusion criteria
Patients who had ﬁxed unresectable tumour peroperatively.
Patients underwent oesophagectomy for non-cancer disease.
Patients with high-grade dysplasia.
2.2. Surgical approach
We used a left thoracotomy only approach (LTO) and standard
Ivor–Lewis approach (IL) depending on the location of the tumour
measured during gastroscopy to achieve curative resection. Left
thoracotomy only approach (LTO) was achieved after a wideanterior splitting of the diaphragmatic hiatus and transhiatal
exposure of the lower posterior mediastinum. All the patients had
standard level II of lymph node clearance and postoperative
management.
2.3. Data collection
Data (age, sex, blood loss, blood transfusion, operation types,
date of operation and date of death) was ascertained from hospital
notes and theatre records. Patients follow up and date of death was
determined from the hospital notes and PA System.
2.4. Blood loss and transfusion
Preoperative haemoglobin of 10 mg/dl or above was an
acceptable level for elective curative oesophagectomy. Any patient
with postoperative haemoglobin of 8 mg/dl or less and symptom-
atic with this level had a blood transfusion. Blood loss was
measured directly from suction collection and by measuring the
weight difference of surgical swabs before and after use.
2.5. Recurrence
Local, regional, transcoelomic (pleural or peritoneal) and distant
(haematogenous) metastasis are considered as manifestation of
recurrence of the disease. Recurrence at cervical, celiac, mediastinal
and paraaortic lymph nodes was classiﬁed as loco-regional recur-
rence. Recurrence of disease was only diagnosed on clinical
grounds picked up on OGD or CT depending on the symptomatic
presentation of the postoperative patient.
2.6. Follow up
All patients were seen at the outpatient clinic at 3 monthly
intervals for the ﬁrst year and then every 6 months thereafter for
5 years. After 5 years, an annual follow up has been carried out on
all patients. Radiological modalities, haematological and endo-
scopic interventions were not used routinely during follow up.
However when recurrencewas suspected, additional investigations
were performed when clinically indicated.
2.7. Statistical analysis
Statistical package for social science (SPSS) version 13.0 was
used to perform statistical analyses of the available data. Time to
event was measured from the date of ﬁrst deﬁnitive treatment
(surgical) till the date of recorded death. Any cause of death is
recorded as an event, which may be directly related or unrelated to
disease progression or relapse.
Mann–Whitney U-test was used to compare the amount of
blood loss and the median number of units transfused for both HS
and HS control. Survival analysis was performed by Cox Regression
(backward stepwise log ratio) with all variables. Death within
30 days of the surgical resection and survival time were used as
endpoints for assessing postoperative death and prognostic factors.
Table 2
LTO versus Ivor–Lewis approach.
Harmonic scalpel Electrocautery
Ivor–Lewis oesophagectomy n ¼ 19 (43%) n ¼ 38 (39%)
Left thoracotomy only n ¼ 25 (53%) n ¼ 60 (61%)
Table 4
Median blood transfusion.
Harmonic scalpel Electrocautery
Blood transfused (median) 0 (0, 2) 2 (0,4)
p-value 0.003
N. Waraich et al. / International Journal of Surgery 7 (2009) 330–3333323. Results
Our cohort included a total of 142 patients who underwent
elective oesophagectomy from 1999 to 2004. Group 1 included 98
patients and Group 2 consisted of 44 patients.
Median age was 66 years in the 1st group (range 44–84 years)
and it was 64 years in the 2nd group (range 39–80 years). Males
have clearly dominated both the groups with male:female ratio of
11:3 and 41:3 in Groups 1 and 2 respectively. Majority of patients in
both groups had T3-stage and N1-stage of tumour according to
TNM classiﬁcation (Table 1). Patients who had oesophagectomy via
LTO approach dominated both the groups and Ivor–Lewis oeso-
phagectomy was comparable among the groups (Table 2).
Mann–Whitney U-test was applied for assessment of blood loss
and blood transfusion. The median blood loss in the HS group was
500 ml (range 26–1500 ml) and 700 ml (range 300–3000) in elec-
trocautery group (Table 3).
However the median number of units of blood transfused in HS
(Group 2) was 0 (range 0–2 units) and was signiﬁcantly less than
Group 1 (p < 0.003) (Table 4).
Complication rate was 13.6% in Group 2 and it was 17.3% in
Group 1. Most common complication was respiratory/pulmonary.
The survival in harmonic group was far better than electro-
diathermy group which was in parallel with the blood transfusion
(Table 5). One, 2 and 3 year survival rates in harmonic group were
77%, 50% and 45% respectively. Whereas survival rates in 1, 2, 3 and
5 year in electrocautery group were 67%, 45%, 31% and 28%
(Kaplan–Meier curve)(Graph 1).
Mortality rate was 2% in the harmonic group and it was 3% in the
electrocautery group with p-value ¼ 0.14 (Table 4).4. Discussion
Bleeding following major surgery remains a major potential
problem. Numerous approaches to altering, modifying, or aug-
menting haemostatic system activation are used perioperatively to
treat patients. Therefore increasingly, studies are being conducted
and published to help clinicians further improve patient
management.
Perioperative allogenic blood transfusion is associated with
tumour recurrence and decreased survival in surgery for gastroin-
testinal malignancies as well as an increased incidence of post-
operative infection.19–21 Murata et al. conducted their study on the
effect of perioperative blood transfusion in the surgery of gastric
cancer patients and they concluded that CD4/CD8 ratio at 3 months
after surgerywas signiﬁcantly lower in the transfused group than in
the non-transfused group. The higher CD4/CD8 ratio in the non-
transfused group supports the notion that transfusion causes
a broad spectrum of immunosuppression.22Table 3
Median blood loss in both groups.
Harmonic scalpel Electrocautery
Blood loss (median) 500 (26, 1500) 700 (300, 3000)
p-value 0.123
Note Blood loss is in millilitres.Our data has demonstrated the less blood loss and subsequent
less blood transfusion in a group of patients who had oesopha-
gectomy done with HS. Collision and colleagues in tonsillectomy
patients previously described this. They showed less intraoperative
bleeding among patients who underwent HS tonsillectomy versus
conventional tonsillectomy.23
Our study also shows less mortality and better survival in the HS
group that may not be directly related to the device used. However
an obvious reason of less blood loss and less transfusion seems to
have an indirect relationship with survival as well as a mortality
rate. This is well supported by Vallejo and his colleagues high-
lighted factors affecting both cellular and humoral immune func-
tions. Possible immunosuppressive factors during perioperative
period include anaesthetic agents, opioids, surgery, blood trans-
fusion, temperature changes, pain and psychological stress. It is
mediated via decreased activity of the natural killer cells, which
subsequently increased risk mortality and cancer.24
Takemura et al. demonstrated an adverse affect of allogenic
blood transfusion on survival of patients with oesophageal cancer.
Furthermore they also suggested that the avoidance of blood
transfusion may reduce the incidence of postoperative infections
and has a favourable effect on the survival of patients at high risk
for recurrence.15
Similarly Kinoshita and colleagues proved that the autologus
blood transfusion lessens the need of allogenic blood transfusion,
which subsequently reduces the risk of infection in oesophageal
cancer surgery. Blood loss itself is not an independent indicator of
better survival. However blood transfusion does have impact on
survival.25,26
HS is not electrically but ultrasonically activated therefore it can
be safely and effectively used in pacemaker-dependent patients
without adverse temporary or permanent effects to the patients
pacemaker system.27 Also there is no danger from stray currents or
capacitative coupling, and there is no nerve stimulation, electrical
interference, requirements for ground pad, nor is there a produc-
tion of toxic smoke which occurs with electrosurgery.9 Other
beneﬁts of HS includes less postoperative pain.28
Electrocautery, laser tissue ablation and HS tissue dissection all
create a gaseous by-product known as smoke that can be seen and
smelled. Electrocautery creates particles with the smallest mean
aerodynamic size 0.07 mm, laser produces 0.31 mm and the largest
of all is produced by the HS, size 0.35–6.5 mm. Smaller particles are
more of a concern from a chemical point of view and larger parti-
cles aremore of a concern from a biological stand point.29 Therefore
surgical smoke is a biohazard and cannot be ignored.
One can argue the size of particles produced by HS and their
viability. This has already been dealt with by Nduka et al., who
performed morphological examination of cellular debris and
collected smoke during cancer surgery in rats. They showed that
cellular debris is composed largely of amorphous cell fragments
liberated as a result of the cavitational effect. In their study they
ﬁnally concluded that although tissue ablation with HS liberatesTable 5
Comparing mortality rate in both groups.
Harmonic scalpel Electrocautery
Mortality rate 2% 3%
p-value 0.14
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Graph 1. Kaplan–Meier survival curve for both groups.
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cancer cells.9
We did not directly measure the cost effectiveness of HS in this
study. However Cakir et al. previously has compared the cost
effectiveness of HS with the diathermy in spinal surgery. They
analysed blood loss and over all costs for blood products in 100
patients divided into HS and electrocautery group. Blood loss was
less in the HS group with p < 0.001 and the cost of blood products
p < 0.001. The overall costs, including costs for HS, remained
neutral.30
In different studies it was found that HS offers many beneﬁts to
the patients including smaller incision, less damage to the tissue,
reduced scarring, less pain (decreased lateral thermal injury
0–1.5 mm deep at surgical site which subsequently causes less
pain), quick recovery and a shorter hospital stay.31 However in our
study both groups have a comparable duration of hospital stay.
None of the patients in the HS group had a wound infection.
5. Conclusion
In conclusion we suggest HS can reduce blood loss and trans-
fusion perioperatively. This affects the surgical outcome and
reduces the complications too. HS may have an indirect role in
improving survival. Therefore HS is a safe and effective alternative
to electrocautery in oesophageal surgery.Conﬂict of interest statement
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